IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 2,705.00
-140.00 (-4.92%)
Oct 12, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 37.92 billion as of October 12, 2026. It is the 34,484th most valuable company in the world and the 2,012th biggest in South Korea. Its market cap has decreased by 75.07% in one year.
Market Cap
37.92B
Enterprise Value
20.27B
Revenue
5.60B
Global Rank
Country Rank
#2,012 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 37.92B, a decrease of -92.47%. That is a compound annual growth rate of -64.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 37.92B | -72.65% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 162.00B |
| Genexine | 132.12B |
| MedPacto | 102.31B |
| Vaxcell-Bio Therapeutics | 101.05B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 71.63B |
| Amicogen | 69.47B |
| ENCell | 64.74B |